ecklonialactone B: isolated from the brown alga Ecklonia stolonifera; RN refers to (1aS-(1aR*,2aS*,3R*,13Z,14aR*,14bS*))-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6438442 |
| MeSH ID | M0230016 |
| Synonym |
|---|
| ecklonialactone b |
| 121923-96-4 |
| oxireno(3,4)cyclopent(1,2-c)oxacyclotetradecin-5(2h)-one, 3-ethyl-1a,2a,3,6,7,8,9,10,11,12,14a,14b-dodecahydro-, (1as-(1ar*,2as*,3r*,13z,14ar*,14bs*))- |
| (12e,17s)-2-ethyl-3,16-dioxatricyclo[12.4.0.015,17]octadec-12-en-4-one |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||